MediWound Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $17M-16.1% YoYTTM through 31 Dec 2025
Net Income -$23.9MTTM through 31 Dec 2025
Free Cash Flow -$21.6MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 19.2% |
| EBITDA Margin | -145.5% |
| Operating Margin | -149.0% |
| Net Margin | -140.8% |
Returns
-54.7%ROE
-27.7%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.33x
Net Debt-$53.6Mnet cash position
Cash & Equivalents$4.8M
Quality Metrics
Piotroski F-Score3 / 9
FCF Margin-127.5%
Rule of 40-87.9
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $17M
Diluted EPSFY2025: $-2.10
Dividend
No dividend
Capital Allocation
Capex Intensity32.5%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.